A007570 Stock Overview
Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
My Notes
NewNotes are coming soon
Ilyang Pharmaceutical Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩18,850.00 |
| 52 Week High | ₩29,600.00 |
| 52 Week Low | ₩16,200.00 |
| Beta | 0.0089 |
| 1 Month Change | -5.75% |
| 3 Month Change | 5.90% |
| 1 Year Change | -12.93% |
| 3 Year Change | -22.43% |
| 5 Year Change | -54.41% |
| Change since IPO | 224.10% |
Recent News & Updates
Recent updates
Is Ilyang PharmaceuticalLtd (KRX:007570) A Risky Investment?
Apr 04
Should You Be Adding Ilyang PharmaceuticalLtd (KRX:007570) To Your Watchlist Today?
Mar 14Ilyang Pharmaceutical Co.,Ltd (KRX:007570) Shares May Have Slumped 36% But Getting In Cheap Is Still Unlikely
Mar 14Declining Stock and Decent Financials: Is The Market Wrong About Ilyang Pharmaceutical Co.,Ltd (KRX:007570)?
Feb 22Did Business Growth Power Ilyang PharmaceuticalLtd's (KRX:007570) Share Price Gain of 159%?
Feb 01Is Ilyang Pharmaceutical Co.,Ltd's (KRX:007570) Shareholder Ownership Skewed Towards Insiders?
Jan 11
Here's Why Ilyang PharmaceuticalLtd (KRX:007570) Can Manage Its Debt Responsibly
Dec 24A Look At The Intrinsic Value Of Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
Dec 06Ilyang Pharmaceutical Co.,Ltd (KRX:007570) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Nov 18Shareholder Returns
| A007570 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 1.3% | 1.5% | 2.6% |
| 1Y | -12.9% | -13.0% | -11.8% |
Return vs Industry: A007570 matched the KR Pharmaceuticals industry which returned -13% over the past year.
Return vs Market: A007570 underperformed the KR Market which returned -11.8% over the past year.
Price Volatility
| A007570 volatility | |
|---|---|
| A007570 Average Weekly Movement | 5.2% |
| Pharmaceuticals Industry Average Movement | 4.9% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in KR Market | 10.6% |
| 10% least volatile stocks in KR Market | 3.1% |
Stable Share Price: A007570 is not significantly more volatile than the rest of KR stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: A007570's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1946 | 675 | Dong-Yeon Kim | https://www.ilyang.co.kr |
Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and beverages.
Ilyang Pharmaceutical Co.,Ltd Fundamentals Summary
| A007570 fundamental statistics | |
|---|---|
| Market Cap | ₩340.94b |
| Earnings (TTM) | ₩21.26b |
| Revenue (TTM) | ₩389.45b |
16.0x
P/E Ratio0.9x
P/S RatioIs A007570 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A007570 income statement (TTM) | |
|---|---|
| Revenue | ₩389.45b |
| Cost of Revenue | ₩168.34b |
| Gross Profit | ₩221.11b |
| Other Expenses | ₩199.85b |
| Earnings | ₩21.26b |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.18k |
| Gross Margin | 56.78% |
| Net Profit Margin | 5.46% |
| Debt/Equity Ratio | 28.8% |
How did A007570 perform over the long term?
See historical performance and comparison